|
TANC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
2.46360043476557E-10 |
| Normal-vs-Stage3 |
4.49149994974363E-09 |
| Normal-vs-Stage4 |
2.212800E-04 |
| Stage1-vs-Stage2 |
5.653800E-01 |
| Stage1-vs-Stage3 |
6.220200E-02 |
| Stage1-vs-Stage4 |
6.064500E-02 |
| Stage2-vs-Stage3 |
3.917000E-01 |
| Stage2-vs-Stage4 |
2.626000E-01 |
| Stage3-vs-Stage4 |
6.028400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
1.77247105881406E-12 |
| Normal-vs-Asian |
2.67710000001475E-06 |
| Caucasian-vs-AfricanAmerican |
2.580000E-01 |
| Caucasian-vs-Asian |
9.145400E-01 |
| AfricanAmerican-vs-Asian |
6.278400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
7.50559947526597E-10 |
| Male-vs-Female |
8.45620000000658E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.32709954137056E-10 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
1.04110053911199E-11 |
| Normal-vs-Extreme_Obese |
1.69409997141656E-09 |
| Normal_Weight-vs-Extreme_Weight |
8.660300E-02 |
| Normal_Weight-vs-Obese |
7.599800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.934370E-01 |
| Extreme_Weight-vs-Obese |
1.521940E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.827200E-01 |
| Obese-vs-Extreme_Obese |
9.203800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.064600E-03 |
| Normal-vs-Age(41-60Yrs) |
5.6621374255883E-15 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.08929976150307E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.529380E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.772160E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.252340E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.795000E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.390100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.681000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
<1E-12 |
| Normal-VS-KIRP CIMP |
2.183800E-01 |
| Normal-VS-Unclassified PRCC |
7.2108000004345E-07 |
| Type1 PRCC-VS-Type2 PRCC |
9.300400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.413850E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.954110E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.579860E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.372030E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.939600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
2.371300E-04 |
| Normal-vs-N2 |
7.721800E-03 |
| N0-vs-N1 |
2.538100E-02 |
| N0-vs-N2 |
9.190200E-02 |
| N1-vs-N2 |
9.821800E-01 |
|
|
